BackBeauty Health Company (The) Overview

Beauty Health Company (The) Total Current Liabilities

Beauty Health Company (The)'s total current liabilities is $70M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$69.80M
↑ 12.76% YoYΔ $7.90M vs prior year quarter

Peer trimmed avg / median

Loading

Beauty Health Company (The) Total Current Liabilities History

Loading

Beauty Health Company (The) vs. peers: Total Current Liabilities Comparison

Loading

Beauty Health Company (The) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Beauty Health Company (The) (SKIN) FAQ

Beauty Health Company (The) (SKIN) currently reports a total current liabilities of $70M as of September 2026. That compares with $62M in the prior-year period — up 12.8% year over year. Use the charts on this page to explore Beauty Health Company (The)'s total current liabilities history and peer comparisons.

Beauty Health Company (The)'s total current liabilities increased from $62M to $70M — a 12.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Beauty Health Company (The) reported $70M in total current liabilities as of September 2026. That compares with $62M in the prior-year period — up 12.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $70M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Beauty Health Company (The), and consider following SKIN for alerts when major investors trade the stock.

Beauty Health Company (The) is classified in the Healthcare sector. On total current liabilities, it currently shows $70M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SKIN with unrelated industries.